Invivyd secures $30M non-dilutive term loan facility with Silicon Valley Bank

Invivyd, Inc.

Up to $30M term loan facility split into three $10M tranches available upon meeting financial covenants and net product revenue milestones.
Interest rate at WSJ prime minus 0.25% (floor 6%, cap 9%), maturity March 1, 2029; prepayment premiums 3%-0% sliding over three years.
Loan secured by substantially all assets excluding IP; financial covenants include minimum net product revenue and minimum cash/EBITDA thresholds.
Proceeds for working capital; company highlights non-dilutive nature and potential FDA alignment on VYD2311 as catalyst.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.